In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season

Comparison with the 2010–11 to 2016–17 seasons

Hideyuki Ikematsu, Naoki Kawai, Yong Jeong, Takuma Bando, Norio Iwaki, Seizaburo Kashiwagi

Research output: Contribution to journalArticle

Abstract

To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the viruses epidemic in the 2017-18 Japanese influenza season, we measured the 50% inhibitory concentration (IC50) for influenza virus isolates from patients and compared them with the results from the 2010–11 to 2016-17 seasons. Viral isolation was done with specimens obtained prior to treatment, and the type and subtype was determined by RT-PCR using type- and subtype-specific primers. The IC50 was determined by a neuraminidase inhibition assay using a fluorescent substrate. A total of 237 virus isolates, 50 A(H1N1)pdm09, 92 A(H3N2), and 95 B were measured. No A(H1N1)pdm09 with highly reduced sensitivity for oseltamivir was found in the 2017-18 season. No isolates with highly reduced sensitivity to the four NAIs have been found for A(H3N2) or B from the 2010–11 to 2017-18 seasons. The geometric mean IC50s of the four NAIs were quite consistent during the eight studied seasons. These results indicate that the sensitivity to the four commonly used NAIs has been maintained.

Original languageEnglish
Pages (from-to)649-652
Number of pages4
JournalJournal of Infection and Chemotherapy
Volume25
Issue number8
DOIs
Publication statusPublished - Aug 1 2019

Fingerprint

Neuraminidase
Inhibitory Concentration 50
Viruses
Oseltamivir
Orthomyxoviridae
Human Influenza
In Vitro Techniques
Polymerase Chain Reaction

All Science Journal Classification (ASJC) codes

  • Microbiology (medical)
  • Pharmacology (medical)
  • Infectious Diseases

Cite this

In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season : Comparison with the 2010–11 to 2016–17 seasons. / Ikematsu, Hideyuki; Kawai, Naoki; Jeong, Yong; Bando, Takuma; Iwaki, Norio; Kashiwagi, Seizaburo.

In: Journal of Infection and Chemotherapy, Vol. 25, No. 8, 01.08.2019, p. 649-652.

Research output: Contribution to journalArticle

@article{28956c1a3828494a9ec1ad5764f28aad,
title = "In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season: Comparison with the 2010–11 to 2016–17 seasons",
abstract = "To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the viruses epidemic in the 2017-18 Japanese influenza season, we measured the 50{\%} inhibitory concentration (IC50) for influenza virus isolates from patients and compared them with the results from the 2010–11 to 2016-17 seasons. Viral isolation was done with specimens obtained prior to treatment, and the type and subtype was determined by RT-PCR using type- and subtype-specific primers. The IC50 was determined by a neuraminidase inhibition assay using a fluorescent substrate. A total of 237 virus isolates, 50 A(H1N1)pdm09, 92 A(H3N2), and 95 B were measured. No A(H1N1)pdm09 with highly reduced sensitivity for oseltamivir was found in the 2017-18 season. No isolates with highly reduced sensitivity to the four NAIs have been found for A(H3N2) or B from the 2010–11 to 2017-18 seasons. The geometric mean IC50s of the four NAIs were quite consistent during the eight studied seasons. These results indicate that the sensitivity to the four commonly used NAIs has been maintained.",
author = "Hideyuki Ikematsu and Naoki Kawai and Yong Jeong and Takuma Bando and Norio Iwaki and Seizaburo Kashiwagi",
year = "2019",
month = "8",
day = "1",
doi = "10.1016/j.jiac.2019.04.007",
language = "English",
volume = "25",
pages = "649--652",
journal = "Journal of Infection and Chemotherapy",
issn = "1341-321X",
publisher = "Elsevier BV",
number = "8",

}

TY - JOUR

T1 - In vitro neuraminidase inhibitory concentration (IC50) of four neuraminidase inhibitors in the Japanese 2017–18 season

T2 - Comparison with the 2010–11 to 2016–17 seasons

AU - Ikematsu, Hideyuki

AU - Kawai, Naoki

AU - Jeong, Yong

AU - Bando, Takuma

AU - Iwaki, Norio

AU - Kashiwagi, Seizaburo

PY - 2019/8/1

Y1 - 2019/8/1

N2 - To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the viruses epidemic in the 2017-18 Japanese influenza season, we measured the 50% inhibitory concentration (IC50) for influenza virus isolates from patients and compared them with the results from the 2010–11 to 2016-17 seasons. Viral isolation was done with specimens obtained prior to treatment, and the type and subtype was determined by RT-PCR using type- and subtype-specific primers. The IC50 was determined by a neuraminidase inhibition assay using a fluorescent substrate. A total of 237 virus isolates, 50 A(H1N1)pdm09, 92 A(H3N2), and 95 B were measured. No A(H1N1)pdm09 with highly reduced sensitivity for oseltamivir was found in the 2017-18 season. No isolates with highly reduced sensitivity to the four NAIs have been found for A(H3N2) or B from the 2010–11 to 2017-18 seasons. The geometric mean IC50s of the four NAIs were quite consistent during the eight studied seasons. These results indicate that the sensitivity to the four commonly used NAIs has been maintained.

AB - To assess the extent of susceptibility to the four most commonly used neuraminidase inhibitors (NAIs) of the viruses epidemic in the 2017-18 Japanese influenza season, we measured the 50% inhibitory concentration (IC50) for influenza virus isolates from patients and compared them with the results from the 2010–11 to 2016-17 seasons. Viral isolation was done with specimens obtained prior to treatment, and the type and subtype was determined by RT-PCR using type- and subtype-specific primers. The IC50 was determined by a neuraminidase inhibition assay using a fluorescent substrate. A total of 237 virus isolates, 50 A(H1N1)pdm09, 92 A(H3N2), and 95 B were measured. No A(H1N1)pdm09 with highly reduced sensitivity for oseltamivir was found in the 2017-18 season. No isolates with highly reduced sensitivity to the four NAIs have been found for A(H3N2) or B from the 2010–11 to 2017-18 seasons. The geometric mean IC50s of the four NAIs were quite consistent during the eight studied seasons. These results indicate that the sensitivity to the four commonly used NAIs has been maintained.

UR - http://www.scopus.com/inward/record.url?scp=85065513322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85065513322&partnerID=8YFLogxK

U2 - 10.1016/j.jiac.2019.04.007

DO - 10.1016/j.jiac.2019.04.007

M3 - Article

VL - 25

SP - 649

EP - 652

JO - Journal of Infection and Chemotherapy

JF - Journal of Infection and Chemotherapy

SN - 1341-321X

IS - 8

ER -